Changing lanes: extending CAR T-cell therapy to high-risk plasma cell dyscrasias.
Saved in:
| Title: | Changing lanes: extending CAR T-cell therapy to high-risk plasma cell dyscrasias. |
|---|---|
| Authors: | Morgan HT; Clinical Development, Oricell Therapeutics, Roseland, NJ, United States., Derman BA; Section of Hematology/Oncology, University of Chicago, Chicago, IL, United States., Ma H; Clinical Development, Oricell Therapeutics, Roseland, NJ, United States., Kumar SK; Department of Hematology, Mayo Clinic, Rochester, MN, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Apr 08; Vol. 16, pp. 1558275. Date of Electronic Publication: 2025 Apr 08 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
